Breaking news
Pfizer will enroll participants as young as 12 in its large, late-stage COVID-19 vaccine trial to understand how it works in a wider age group. The US Food and Drug Administration (FDA) granted permission to the drugmaker and German partner BioNTech SE to enroll the younger participants this month, according to an update on Monday … Read more
US biotech firm Moderna, one of nine companies in the late stages of clinical trials for a Covid-19 vaccine, became the first to publish the complete blueprints of its study following calls for greater transparency. Pfizer, the other American company currently carrying out Phase 3 trials in the US, followed suit a short time later … Read more
Pfizer Inc says it could have results from its late-stage coronavirus vaccine trial available as early as October. On Thursday, CEO Albert Bourla said during a call sponsored by drug industry group International Federation of Pharmaceutical Manufacturers & Associations that 23,000 volunteers have been enrolled in the phase III trial, which began in July. The … Read more
University of Oxford Oxford University academics began developing the ChAdOx1 nCoV-19 vaccine in January. It is now named AZD1222, after the researchers signed a manufacturing partnership with pharmaceutical giant AstraZeneca. Human trials started on April 23 and they are now in the final phase, with trials being carried out in the UK, Brazil and South … Read more
Pfizer Inc signs multi-year deal to manufacture Gilead’s coronavirus antiviral remdesivir to boost production of the drug Pfizer Inc has signed a multi-year deal with Gilead Sciences Inc to manufacture and supply the antiviral remdesivir The drug is the only one approved in the US to treat coronavirus patients by emergency use after it was … Read more
German biotech BioNTech and US drugmaker Pfizer said on Monday they are launching a pivotal global study to evaluate their lead COVID-19 vaccine candidate. If the study is successful, the companies could submit the vaccine for regulatory approval as early as October, putting them on track to supply up to 100 million doses by the … Read more
Britain has signed deals with two foreign pharmaceutical giants for 90million doses of new coronavirus vaccines with the option of buying 40million more, it was revealed today. Agreement has been reached for 30million doses from BioNTech and German firm Pfizer and 60million doses from France’s Valneva. The figure of 90million is in addition to the 100million … Read more
Pfizer and German biotech company say they expect their coronavirus vaccine to be ready for approval by the end of the year as trials on 30,000 people begins Pfizer and its German partner BioNTech SE are entering large-scale human trials this summer for their coronavirus vaccine They expect results to come back relatively quickly and … Read more
Experimental coronavirus vaccine from Pfizer triggered levels of antibodies up to THREE TIMES greater than those seen in recovered patients, early data shows Researchers randomly gave 45 healthy volunteers either a low dose, a medium dose or a high dose of a coronavirus vaccine, or a placebo Those who received the vaccine were given two shots, except … Read more
Pfizer says its coronavirus vaccine could be ready in the Autumn in global race to beat the pandemic Major US pharmaceutical corporation said human testing underway in August ‘This is a crisis right now, and a solution is desperately needed by all’ – Pfizer boss Confirmed cases of coronavirus in the US stand at more than … Read more